Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints... see more

OTCPK:BIOAQ - Post Discussion

BioAmber Inc. > Bought back at ,085
View:
Post by bobyback on Feb 14, 2018 10:14am

Bought back at ,085

Thank you selles
Comment by TradingDweeb on Feb 14, 2018 11:22am
I would of waited til tomorrow, you never know what tomorrow's news might bring.
Comment by mumfordsen on Feb 14, 2018 12:11pm
Unless I bought this at 7 cents, I'm just gonna watch from the sidelines. If everything is okay in tomorrow's meeting, you guys who bought today will be rewarded nicely.
Comment by bobyback on Feb 14, 2018 12:33pm
The worts you will find is they lower the pp and going to TSX venture... So what lol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities